These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7004361)

  • 21. Alopecia areata: infiltration of Th17 cells in the dermis, particularly around hair follicles.
    Tanemura A; Oiso N; Nakano M; Itoi S; Kawada A; Katayama I
    Dermatology; 2013; 226(4):333-6. PubMed ID: 23838575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alopecia areata, endocrine function, and autoantibodies in patients 16 years of age or younger.
    Milgraum SS; Mitchell AJ; Bacon GE; Rasmussen JE
    J Am Acad Dermatol; 1987 Jul; 17(1):57-61. PubMed ID: 3301924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alopecia areata and auto-immunity.
    Friedmann PS
    Br J Dermatol; 1981 Aug; 105(2):153-7. PubMed ID: 7284245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical and electron microscopic characterization of the cellular infiltrate in alopecia (areata, totalis, and universalis).
    Ranki A; Kianto U; Kanerva L; Tolvanen E; Johansson E
    J Invest Dermatol; 1984 Jul; 83(1):7-11. PubMed ID: 6376642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type 1 interferon signature in the scalp lesions of alopecia areata.
    Ghoreishi M; Martinka M; Dutz JP
    Br J Dermatol; 2010 Jul; 163(1):57-62. PubMed ID: 20346028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral cyclosporine for the treatment of alopecia areata. A clinical and immunohistochemical analysis.
    Gupta AK; Ellis CN; Cooper KD; Nickoloff BJ; Ho VC; Chan LS; Hamilton TA; Tellner DC; Griffiths CE; Voorhees JJ
    J Am Acad Dermatol; 1990 Feb; 22(2 Pt 1):242-50. PubMed ID: 2138175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoantibodies to DFS70/LEDGF are increased in alopecia areata patients.
    Okamoto M; Ogawa Y; Watanabe A; Sugiura K; Shimomura Y; Aoki N; Nagasaka T; Tomita Y; Muro Y
    J Autoimmun; 2004 Nov; 23(3):257-66. PubMed ID: 15501396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood lymphocyte subpopulations and antibody dependent, cell-mediated cytotoxicity (ADCC) in alopecia areata and universalis.
    Gu SQ; Ros AM; Thyresson N; Wasserman J
    Acta Derm Venereol; 1981; 61(2):125-9. PubMed ID: 6165187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoimmunity: alopecia areata.
    Hordinsky M; Ericson M
    J Investig Dermatol Symp Proc; 2004 Jan; 9(1):73-8. PubMed ID: 14870990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Smooth muscle antibodies and alopecia areata.
    Main RA; Robbie RB; Gray ES; Donald D; Horne CH
    Br J Dermatol; 1975 Apr; 92(4):389-93. PubMed ID: 1156552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of infiltrating T cells in human scalp explants from alopecia areata to SCID nude mice: possible role of the disappearance of CD8+ T lymphocytes in the process of hair regrowth.
    Tsuboi H; Tanei R; Fujimura T; Ohta Y; Katsuoka K
    J Dermatol; 1999 Dec; 26(12):797-802. PubMed ID: 10659500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the expression of cutaneous lymphocyte-associated antigen on the peripheral blood and cutaneous lymphocytes of alopecia areata patients.
    Yano S; Nakamura K; Okochi H; Tamaki K
    Acta Derm Venereol; 2002; 82(2):82-5. PubMed ID: 12125957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T cell subpopulations in alopecia areata.
    Todes-Taylor N; Turner R; Wood GS; Stratte PT; Morhenn VB
    J Am Acad Dermatol; 1984 Aug; 11(2 Pt 1):216-23. PubMed ID: 6384283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA-DR expression by hair follicle keratinocytes in alopecia areata: evidence that it is secondary to the lymphoid infiltration.
    Khoury EL; Price VH; Greenspan JS
    J Invest Dermatol; 1988 Feb; 90(2):193-200. PubMed ID: 2448391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD44 expression in alopecia areata and androgenetic alopecia.
    Sawaya ME; Bakshandeh H; Hordinsky MK; Penneys NS
    J Cutan Pathol; 1994 Jun; 21(3):229-32. PubMed ID: 7525670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T-cell receptor repertoire V beta in alopecia areata.
    Szafer F; Price VH; Oksenberg JR; Steinman L
    J Invest Dermatol; 1995 May; 104(5 Suppl):22S-24S. PubMed ID: 7738379
    [No Abstract]   [Full Text] [Related]  

  • 37. Alopecia areata: a tissue specific autoimmune disease of the hair follicle.
    Gilhar A; Kalish RS
    Autoimmun Rev; 2006 Jan; 5(1):64-9. PubMed ID: 16338213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistological evaluation of alopecia areata treated with squaric acid dibutylester (SADBE).
    Johansson E; Ranki A; Reunala T; Kianto U; Niemi KM
    Acta Derm Venereol; 1986; 66(6):485-90. PubMed ID: 2433867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunological profiles in alopecia areata.
    Galbraith GM; Thiers BH; Vasily DB; Fudenberg HH
    Br J Dermatol; 1984 Feb; 110(2):163-70. PubMed ID: 6607739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study.
    Simonetti O; Lucarini G; Bernardini ML; Simoncini C; Biagini G; Offidani A
    Br J Dermatol; 2004 May; 150(5):940-8. PubMed ID: 15149507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.